Anpario plc (LON:ANP - Get Free Report)'s stock price crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 433.54 ($5.89) and traded as high as GBX 438.80 ($5.97). Anpario shares last traded at GBX 435.50 ($5.92), with a volume of 34,833 shares traded.
Wall Street Analysts Forecast Growth
Separately, Shore Capital reiterated a "house stock" rating on shares of Anpario in a research note on Monday, March 31st.
View Our Latest Research Report on Anpario
Anpario Trading Down 2.1%
The company has a quick ratio of 5.16, a current ratio of 6.15 and a debt-to-equity ratio of 0.10. The stock has a market capitalization of £71.83 million, a P/E ratio of 23.25 and a beta of 0.58. The firm's 50 day simple moving average is GBX 433.54 and its two-hundred day simple moving average is GBX 419.89.
About Anpario
(
Get Free Report)
Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.
Recommended Stories
Before you consider Anpario, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.
While Anpario currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.